Evidence map›Paper›PMID 38889340›Full record

ArticleAmerican journal of respiratory and critical care medicine2024

Biomarkers Unveil Insights into Pathology of Transitional Epithelial States in Pulmonary Fibrosis.

Christopher Ting, Kristine Konopka, Rachel E Benedeck, David W H Riches, Elizabeth F Redente, Justin M Oldham, Rachel L Zemans

Abstract readLetter
In one paragraph

Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Targeting the epithelium in pulmonary fibrosis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  9. Article
  10. Article
  11. Biomarkers Unveil Insights into Pathology of Transitional Epithelial States in Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christopher TingDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine.ORCID 0000-0002-0727-2303
Kristine KonopkaDepartment of Pathology, and.ORCID 0000-0002-4582-0120
Rachel E BenedeckProgram in Cellular and Molecular Biology, School of Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-9580-3882
David W H RichesProgram in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, Colorado.ORCID 0000-0002-9587-3335
Elizabeth F RedenteProgram in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, Colorado.ORCID 0000-0002-8075-4325
Justin M OldhamDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine.ORCID 0000-0003-4957-8869
Rachel L ZemansDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine.ORCID 0000-0003-3537-9869

Funding

PULMONARY CELLULAR AND MOLECULAR BIOLOGY TRAININGT32HL007749 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Robert Pickett Dickson · 1993 to 2026
$19.9M
Targeting early events in MUC5B-driven lung injury and fibrosisP01HL162607 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI David W. Riches · 2023 to 2026
$12.4M
Mechanisms of Alveolar Homeostasis, Injury, Regeneration, and FibrosisR35HL160770 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Rachel Lynne Zemans · 2022 to 2026
$4.3M
Cellular and Molecular Biology at MichiganT32GM145470 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI John Chadwick Brenner · 2022 to 2026
$4.1M
Proteomic Profiling of Idiopathic Pulmonary Fibrosis Progression TrajectoryR01HL169166 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Justin M Oldham · 2023 to 2026
$2.7M
Reducing Fibroblast Persistence in Pulmonary Fibrosis as a Mechanism of ResolutionR01HL147860 · NHLBI · NATIONAL JEWISH HEALTH · PI REDENTE, ELIZABETH FRANCES · 2019 to 2023
$2.7M
Prognostic Biomarker Development in Progressive Fibrosing Interstitial Lung DiseaseR01HL166290 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Justin M Oldham · 2024 to 2026
$2.2M
Regulation and Mechanisms of Transitional Epithelial Cell Senescence in Lung FibrosisF32HL172379 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TING, CHRISTOPHER · 2024 to 2025
$130k
BLRD VA I01 BX003471NHLBI NIH HHS F32 HL172379NHLBI NIH HHS P01 HL162607NHLBI NIH HHS R01 HL147860NHLBI NIH HHS R01 HL166290NHLBI NIH HHS R01 HL169166NHLBI NIH HHS R35 HL160770NHLBI NIH HHS T32 HL007749NIGMS NIH HHS T32 GM145470
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersPulmonary FibrosisHumansMaleBiomarkers

Identifiers

PMID38889340
PMCPMC11389567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.